{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:27Z","timestamp":1791295707944,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2015.21","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T17:04:30Z","timestamp":1426871070000},"page":"e295-e295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis"],"prefix":"10.1038","volume":"5","author":[{"given":"K-H","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-C","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gon-Shen Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-C","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-T","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-H","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-I","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N-W","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-F","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R-K","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-Y","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-C","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"BFbcj201521_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi A, Vainchenker W . Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 2011; 29: 573\u2013582.","journal-title":"J Clin Oncol"},{"key":"BFbcj201521_CR2","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369: 2379\u20132390.","journal-title":"N Engl J Med"},{"key":"BFbcj201521_CR3","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 2013; 369: 2391\u20132405.","journal-title":"N Engl J Med"},{"key":"BFbcj201521_CR4","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1182\/blood-2013-11-538983","volume":"123","author":"G Rotunno","year":"2014","unstructured":"Rotunno G, Mannarelli C, Guglielmelli P, Pacilli A, Pancrazzi A, Pieri L et al. Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood 2014; 123: 1552\u20131555.","journal-title":"Blood"},{"key":"BFbcj201521_CR5","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1038\/bcj.2014.7","volume":"4","author":"V Shivarov","year":"2014","unstructured":"Shivarov V, Ivanova M, Tiu RV . Mutated calreticulin retains structurally disordered C terminus that cannot bind Ca(2+): some mechanistic and therapeutic implications. Blood Cancer J 2014; 4: e185.","journal-title":"Blood Cancer J"},{"key":"BFbcj201521_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/leu.2013.382","volume":"28","author":"J Chi","year":"2013","unstructured":"Chi J, Nicolaou KA, Nicolaidou V, Koumas L, Mitsidou A, Pierides C et al. Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis. Leukemia 2013; 28: 1152\u20131154.","journal-title":"Leukemia"},{"key":"BFbcj201521_CR7","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 2014; 123: 2220\u20132228.","journal-title":"Blood"},{"key":"BFbcj201521_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cca.2014.11.011","volume":"440","author":"KH Lim","year":"2015","unstructured":"Lim KH, Lin HC, Chen CG, Wang WT, Chang YC, Chiang YH et al. Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis. Clin Chim Acta 2015; 440: 133\u2013139.","journal-title":"Clin Chim Acta"},{"key":"BFbcj201521_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijge.2012.07.002","volume":"7","author":"H-C Lin","year":"2013","unstructured":"Lin H-C, Chen CG-S, Chang M-C, Wang W-T, Kao CW, Lo A-C et al. JAK2 V617F mutation in adult Taiwanese patients with essential thrombocythemia: More prevalent in old patient and correlated with higher hemoglobin level and higher leukocyte count. Int J Gerontol 2013; 7: 40\u201344.","journal-title":"Int J Gerontol"},{"key":"BFbcj201521_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijge.2013.01.005","volume":"7","author":"H-C Lin","year":"2013","unstructured":"Lin H-C, Wang S-C, Chen CG-S, Chang M-C, Wang W-T, Su N-W et al. Mutation and lineage analysis of DNMT3A in BCR-ABL1-negative chronic myeloproliferative neoplasms. Int J Gerontol 2013; 7: 186\u2013188.","journal-title":"Int J Gerontol"},{"key":"BFbcj201521_CR11","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.3324\/haematol.2014.115113","volume":"100","author":"S Shirane","year":"2014","unstructured":"Shirane S, Araki M, Morishita S, Edahiro Y, Takei H, Yoo Y et al. JAK2, CALR, and MPL mutation spectrum in Japanese myeloproliferative neoplasms patients. Haematologica 2014; 100: e46\u2013e48.","journal-title":"Haematologica"},{"key":"BFbcj201521_CR12","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/leu.2014.3","volume":"28","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 2014; 28: 1472\u20131477.","journal-title":"Leukemia"},{"key":"BFbcj201521_CR13","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/leu.2014.138","volume":"28","author":"R Fu","year":"2014","unstructured":"Fu R, Xuan M, Zhou Y, Sun T, Bai J, Cao Z et al. Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment. Leukemia 2014; 28: 1912\u20131914.","journal-title":"Leukemia"},{"key":"BFbcj201521_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajh.23665","volume":"89","author":"TL Lasho","year":"2014","unstructured":"Lasho TL, Elliott MA, Pardanani A, Tefferi A . CALR mutation studies in chronic neutrophilic leukemia. Am J Hematol 2014; 89: 450.","journal-title":"Am J Hematol"},{"key":"BFbcj201521_CR15","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood.V124.21.4588.4588","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Ho AK, Pan Q, Racke FK, Jones D . In-frame exon 9 CALR deletions co-occur with other alterations in the JAK-STAT pathway in myeloproliferative neoplasms. Blood 2014; 124: 4588.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201521","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T09:57:23Z","timestamp":1672912643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["BFbcj201521"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2015.21","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]},"assertion":[{"value":"20 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}